Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline
Fierce Biotech
Thu, 08/10/23 - 11:41 am
Tags:
Novo Nordisk, M&A, obesity, Inversago
In the era of blockbuster obesity drugs, a personalized approach could boost outcomes
Pharma Voice
Wed, 08/9/23 - 10:14 am
Tags:
obesity, Phenomix, Novo Nordisk, Ozempic, Wegovy
Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy
Fierce Pharma
Tue, 08/8/23 - 11:25 am
Tags:
Novo Nordisk, Wegovy, clinical trials, cardiovascular disease, obesity
Report: Fewer Adults Are Interested in Weight Loss Drugs If Not Covered by Insurance
MedCity News
Mon, 08/7/23 - 11:12 pm
Tags:
insurance, weight loss, payers, Novo Nordisk, Eli Lilly
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
Tags:
clinical trials, Sarepta Therapeutics, DMD, Elevidys, Bridge Bio, ATTR-CM, acoramidis, Sanofi, Merck KGaA, MS, tolebrutinib, Pfizer, obesity, danuglipron, Novo Nordisk, Ozempic, Verve Therapeutics, heterozygous familial hypercholesterolemia, Roche, lung cancer, tiragolumab, Vertex Pharmaceutical, VS-548, pain, JNJ, Bristol Myers Squibb
Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines
Fierce Pharma
Thu, 08/3/23 - 06:44 pm
Tags:
Novo Nordisk, Eli Lilly, Mounjaro, Ozempic, legal, side effects
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
Tags:
NASH, Boehringer Ingelheim, Zealand Pharma, Akero Therapeutics, Axcella Health, Eli Lilly, Pfizer, Ionis Pharmaceuticals, Cascade, AstraZeneca, Gilead Sciences, Novo Nordisk, Ascletis Pharma, MediciNova
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Motley Fool
Wed, 08/2/23 - 10:16 am
Tags:
Ozempic, Novo Nordisk, weight loss, diabetes
Why Novo Nordisk Stock Thrashed the Market on Monday
Motley Fool
Mon, 07/31/23 - 09:52 pm
Tags:
Novo Nordisk, Ozempic, share repurchase
Stomachs freeze up with Ozempic in rare side effect
Beckers Hospital Review
Wed, 07/26/23 - 09:54 am
Tags:
Novo Nordisk, Ozempic, side effects, gastroparesis
New weight loss drugs carry high price tags and lots of questions for seniors
Medical Marketing and Media
Tue, 07/25/23 - 08:53 pm
Tags:
Seniors, Wegovy, Novo Nordisk, Mounjaro, Eli Lilly, weight loss
Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare
Fierce Pharma
Thu, 07/20/23 - 09:42 pm
Tags:
Novo Nordisk, Eli Lilly, Boehringer Ingelheim, obesity
Novo Nordisk turns RNAi research up to Eleven with new biotech pact
Fierce Biotech
Mon, 07/17/23 - 08:53 am
Tags:
Novo Nordisk, RNA, Eleven Biotherapeutics
Why Novo Nordisk Stock Flew Higher on Friday
Motley Fool
Sun, 07/16/23 - 02:59 pm
Tags:
Novo Nordisk, Wegovy
Pharma finds a way to gain weight
EP Vantage
Thu, 07/13/23 - 09:49 am
Tags:
obesity, Eli Lilly, Novo Nordisk, Wegovy, Mounjaro
Why Novo Nordisk Stock Sank on Tuesday
Motley Fool
Tue, 07/11/23 - 11:23 pm
Tags:
Novo Nordisk, obesity, Wegovy
European regulators probe suicide risk to Ozempic, other Novo drug Saxenda
BioPharma Dive
Mon, 07/10/23 - 09:40 pm
Tags:
Novo Nordisk, Ozempic, Saxenda, EMA, Europe, suicide
Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher
Motley Fool
Thu, 07/6/23 - 11:17 am
Tags:
Novo Nordisk, Ozempic, obesity, diabetes, weight loss, addiction
Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Motley Fool
Mon, 07/3/23 - 10:37 am
Tags:
Pfizer, obesity, lotiglipron, danuglipron, Novo Nordisk, Eli Lilly, Ozempic, Mounjaro
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
Tags:
obesity, clinical trials, Novo Nordisk, Altimmune, Innovent Biologics, Pfizer, Shionogi, Tonix, semaglutide, oxytocin, permvidutide, mazdutide, danuglipron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.